Allogenica
French tech company | Builders Republic
About
Cell therapy company developing off-the-shelf allogeneic CAR-T therapies for blood cancers and rare diseases — using a proprietary stem-cell differentiation process to produce pre-T cells from healthy donors at scale in bioreactors, bypassing the need for patient-specific manufacturing.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2022
- City
- LYON
- Region
- Auvergne-Rhône-Alpes
- Tracked rounds
- 1
- Amount raised
- 0.5 M€ raised since 2020
Funding rounds
- Seed — 2022